Aptar launches sensor counter tech for MDIs
Aptar Pharma has launched a new counter technology for metered dose inhalers (MDIs) it says can help enhance patient adherence.
Aptar Pharma has launched a new counter technology for metered dose inhalers (MDIs) it says can help enhance patient adherence.
Biotrinity 2016
Precision pharmaceutical manufacturing is crucial to the UK’s economy, according to life science minister George Freeman MP.
Indian firm Polydrug Laboratories failed to investigate complaints about APIs containing foreign bodies including hairs and insects, the US FDA says in a Warning Letter.